CapEx at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Capricor Therapeutics's capex?
- Capricor Therapeutics (CAPR) reported capex of $5.12M in Q1 2026.
- How has Capricor Therapeutics's capex changed year-over-year?
- Capricor Therapeutics's capex increased by 471.6% year-over-year, from $896.01K to $5.12M.
- What is the long-term trend for Capricor Therapeutics's capex?
- Over 4 years (2021 to 2025), Capricor Therapeutics's capex has grown at a 24.8% compound annual growth rate (CAGR), from $1.2M to $2.9M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.